Marketing + Technical Info Overview of key characteristics, markets and applications for Complēt PKE Formulations

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to achieve strategic objectives and successfully integrate acquisitions, including Avient Protective Materials; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions. Rose, Vice President, Marketing and Communications, Avient Corporation, +1 440-930-3162, kyle.rose@avient.com

Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials. Even regulations such as the updated European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR) that are only valid for products sold in Europe, should preferably be considered from the start to ensure access to the European market.

These additives are created to enhance bioplastics so you can continue delivering top-end products to the market. Marketing + Technical Info

Our business units provide unique breadth and depth of offerings and expertise that support industry-leading innovation across a diverse array of end markets. We’re the global partner of choice for designers, OEMs, and polymer processors across a wide variety of markets and end-use applications.

Avient’s wide range of medical-grade polymer compounds, colorants, and functional additives can help mitigate risk, streamline your path to market, and deliver desired patient outcomes. Let us assist you in bringing advanced and effective solutions to market. 

Bring visionary new products to market with end-to-end development support.

Avient Introduces Low Shrinkage Alternative to ABS for Luxury Packaging Market

Fourth Quarter Results Adjusted earnings per share increased 38% to $0.36; GAAP EPS loss of $0.16 primarily due to a mark-to-market pension adj

Marketing + Technical Info